OptiBiotix launches two new products at Geneva trade show

The AIM-traded company said the event provided the opportunity to connect with 16,500 industry “decision makers” from the supplements, nutraceutical, functional food and beverage industries.

Its board said the event is viewed as “one of the world's leading” trade fairs for the food and drinks industry.

OptiBiotix said it launched the first of its range of heart health products containing LPLDL called CholBiome and CardioBiome, and its SlimBiome weight management technology.

Both product types were exhibited in the ‘New Products Zone’ and at Sacco's and Nutrilinea's stands.

Sacco and Nutrilinea are OptiBiotix's European manufacturing and formulation partners and reportedly have an extensive European network to “maximise the commercial opportunity” provided by the products.

Both LPLDL and SlimBiome were extremely well received, the OptiBiotix board said, with high interest in the distribution and sale of the products from partners across Europe, Japan, India, Asia, Australia and the US.

“We are extremely pleased with the very high level of interest from both national and multinational companies interested in selling our products,” said CEO Stephen O'Hara.

“This has already resulted in some companies sending through draft contracts.”

O’Hara said the company anticipated that the interest would start to generate revenues from both ingredient supply, and as a component in “high value” white label and branded formulations and presentations, across multiple territories.

“We are at the start of the commercialisation process but are really excited at the high level of interest in our products.

“We look forward to building commercial partnerships, market presence, and multiple revenue streams in both consumer health and pharmaceutical markets around the world.”